Ajanta Pharma Ltd. | Mutual Funds
Mutual Funds that own Ajanta Pharma Ltd.
Matthews India Fund
2,992,070
3.4%
0
2.47%
06/29/2018
Motilal Oswal MOSt Focused Multicap 35
2,357,379
2.68%
0
2.13%
08/31/2018
SBI Magnum Balanced Fund - 1995
1,927,000
2.19%
570,000
1.13%
06/30/2018
UTI - Equity Fund
619,997
0.7%
0
0.89%
08/31/2018
Vanguard Emerging Markets Stock Index Fund
333,758
0.38%
0
0.01%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
309,280
0.35%
29,270
0.02%
04/30/2018
Vanguard Total International Stock Index Fund
306,004
0.35%
0
0%
07/31/2018
303,481
0.35%
87,180
1.37%
12/31/2017
iShares Core MSCI Emerging Markets ETF
283,464
0.32%
0
0.01%
09/05/2018
Religare Invesco Contra Fund
232,533
0.26%
99,544
1.19%
08/31/2018
| Address |
Ajanta House
Mumbai Maharashtra 400067
India
|
|
Employees
|
- |
| Website |
http://www.ajantapharma.com |
| Updated |
09/14/2018 |
| Ajanta Pharma Ltd. operates as a pharmaceutical formulation company, which engages in the manufacturing and marketing of pharmaceutical products. It operates through the following businesses: Branded Generics, Generics, and Institutions. The Branded Generics business offers branded offers products targeting therapeutic segments for treatment of patients. |
